Fernando Lopes Selected Research

2- (5- methylhexahydropyrrolo(3,4- c)pyrrol- 2- yl)xanthen- 9- one

2/2016

Involvement of Mast Cells in α7 Nicotinic Receptor Agonist Exacerbation of Freund's Complete Adjuvant-Induced Monoarthritis in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fernando Lopes Research Topics

Disease

10	Inflammation (Inflammations) 10/2020 - 08/2009
9	Colitis 11/2020 - 06/2015
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2022 - 06/2015
6	Infections 01/2021 - 04/2016
6	Arthritis (Polyarthritis) 10/2020 - 01/2011
3	Pain (Aches) 10/2020 - 02/2016
3	Necrosis 01/2019 - 01/2011
2	Arthralgia (Joint Pain) 10/2020 - 01/2019
1	Optic Atrophy 01/2021
1	Myocardial Infarction 01/2020
1	Rheumatic Diseases (Rheumatism) 01/2019
1	Hyperalgesia 01/2019
1	Neuroinflammatory Diseases 01/2019
1	Ischemia 01/2018
1	Neoplasms (Cancer) 11/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2017
1	Hyperplasia 04/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2016
1	Hepatitis 08/2013
1	Hypoglycemia (Reactive Hypoglycemia) 08/2013
1	Anaphylaxis (Anaphylactic Shock) 08/2013
1	Neutropenia 08/2013
1	Shock 08/2013
1	Poisoning 08/2013
1	Pleurisy (Pleuritis) 08/2009

Drug/Important Bio-Agent (IBA)

11	AntigensIBA 10/2020 - 08/2009
5	CytokinesIBA 01/2019 - 06/2015
5	DinitrobenzenesIBA 01/2019 - 04/2016
5	2,4-dinitrofluorobenzene sulfonic acidIBA 01/2019 - 04/2016
4	Interleukin-10 (Interleukin 10)IBA 01/2019 - 12/2016
4	AcidsIBA 01/2019 - 04/2016
2	Caspase 3 (Caspase-3)IBA 01/2021 - 08/2012
2	Hepatitis delta Antigens (HDAg)IBA 01/2019 - 12/2016
2	Proteins (Proteins, Gene)FDA Link 11/2018 - 07/2017
2	Sulfonic AcidsIBA 11/2018 - 12/2016
2	InterleukinsIBA 01/2018 - 01/2011
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2018 - 12/2016
2	Dextrans (Dextran)FDA Link 01/2018 - 12/2016
2	Interleukin-4 (Interleukin 4)IBA 01/2018 - 04/2016
2	NF-kappa B (NF-kB)IBA 05/2010 - 08/2009
2	Phosphodiesterase 4 InhibitorsIBA 05/2010 - 08/2009
2	RolipramIBA 05/2010 - 08/2009
1	Cytochromes c (Cytochrome c)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Apoptosis Inducing FactorIBA 01/2021
1	CathelicidinsIBA 11/2020
1	Imipramine (Janimine)FDA LinkGeneric 10/2020
1	Dipyrone (Metamizole)IBA 10/2020
1	Analgesics (Analgesic Drugs)IBA 10/2020
1	Antidepressive Agents (Antidepressants)IBA 10/2020
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Etanercept (Enbrel)FDA Link 01/2019
1	Thymic Stromal LymphopoietinIBA 12/2018
1	Interleukin-33IBA 12/2018
1	Death-Associated Protein KinasesIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Biological ProductsIBA 11/2017
1	NucleotidesIBA 07/2017
1	Adenosine Triphosphate (ATP)IBA 07/2017
1	Interleukin-17 (Interleukin 17)IBA 12/2016
1	Interferon-gamma (Interferon, gamma)IBA 12/2016
1	MitogensIBA 12/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016
1	Messenger RNA (mRNA)IBA 04/2016
1	Interleukin-5 (Interleukin 5)IBA 04/2016
1	Interleukin-13IBA 04/2016
1	AntibodiesIBA 04/2016
1	Interleukin-22 (IL-22)IBA 04/2016
1	2- (5- methylhexahydropyrrolo(3,4- c)pyrrol- 2- yl)xanthen- 9- oneIBA 02/2016
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 02/2016
1	methyllycaconitineIBA 02/2016
1	Cholinergic Agents (Cholinergics)IBA 02/2016
1	fluorescein isothiocyanate dextranIBA 06/2015
1	src-Family KinasesIBA 06/2015
1	Phosphotransferases (Kinase)IBA 06/2015
1	Pharmaceutical PreparationsIBA 08/2013
1	Neutralizing AntibodiesIBA 08/2012
1	GlucocorticoidsIBA 08/2012
1	Annexin A1IBA 08/2012
1	Superoxide DismutaseIBA 09/2011
1	CaspasesIBA 05/2010
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 05/2010
1	ColforsinIBA 08/2009
1	Cyclic AMP (AMP, Cyclic)IBA 08/2009
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 08/2009

Therapy/Procedure

4	Therapeutics 03/2022 - 06/2015
1	Intraventricular Infusions 10/2020
1	Patient Readmission 01/2020
1	Aftercare (After-Treatment) 01/2019
1	Immunotherapy 11/2018
1	Operative Surgical Procedures 01/2018
1	Surgical Amputation (Amputations) 01/2018
1	Intraperitoneal Injections 12/2016
1	Intra-Articular Injections 02/2016
1	Length of Stay 01/2016
1	Anesthesia 08/2013